98 related articles for article (PubMed ID: 9027424)
1. Significant reduction of the bias among commercial immunoassays for lipoprotein(a) after use of a uniform calibrator.
Lippi G; Lo Cascio C; Ruzzenente O; Brentegani C; Guidi G
Clin Chim Acta; 1996 Dec; 256(2):125-34. PubMed ID: 9027424
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the new automated ELISA Vidas Lp(a) assay. Comparison with an immunonephelemetric method.
Mesli S; Demailly S; Le Moigne F; Derache P; Jouzier E
Clin Chim Acta; 1998 Apr; 272(2):183-95. PubMed ID: 9641359
[TBL] [Abstract][Full Text] [Related]
3. Comparison of a new immunoturbidometric assay of human serum lipoprotein (a) to the ELISA and the IRMA methods.
Sundvall J; Sulonen GB; Hiltunen O; Kiuru J; Pursiainen M; Jauhiainen M
Scand J Clin Lab Invest; 1995 Apr; 55(2):171-80. PubMed ID: 7667610
[TBL] [Abstract][Full Text] [Related]
4. Effects of anticoagulants on lipoprotein(a) measurements with four commercial assays.
Lippi G; Giampaolo L; Guidi G
Eur J Clin Chem Clin Biochem; 1996 Mar; 34(3):251-5. PubMed ID: 8721413
[TBL] [Abstract][Full Text] [Related]
5. Fully mechanized latex immunoassay for serum lipoprotein(a).
Abe A; Yoshimura Y; Sekine T; Maeda S; Yamashita S; Noma A
Clin Chim Acta; 1994 Mar; 225(2):105-13. PubMed ID: 8088000
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the analytical performances of a new fully automated commercial immunonephelometric assay for lipoprotein(a).
Lippi G; Ruzzenente O; Brentegani C; Pierotti A; Guidi G
Clin Chem Lab Med; 1998 Sep; 36(9):719-23. PubMed ID: 9804397
[TBL] [Abstract][Full Text] [Related]
7. Comparison of lipoprotein (a) serum concentrations measured by six commercially available immunoassays.
Scharnagl H; Stojakovic T; Dieplinger B; Dieplinger H; Erhart G; Kostner GM; Herrmann M; März W; Grammer TB
Atherosclerosis; 2019 Oct; 289():206-213. PubMed ID: 31493849
[TBL] [Abstract][Full Text] [Related]
8. Use of a reference material proposed by the International Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein(a).
Marcovina SM; Albers JJ; Scanu AM; Kennedy H; Giaculli F; Berg K; Couderc R; Dati F; Rifai N; Sakurabayashi I; Tate JR; Steinmetz A
Clin Chem; 2000 Dec; 46(12):1956-67. PubMed ID: 11106328
[TBL] [Abstract][Full Text] [Related]
9. Standardization of Lp(a) measurements.
Albers JJ; Marcovina SM
Chem Phys Lipids; 1994 Jan; 67-68():257-63. PubMed ID: 8187222
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of coronary risk: a new technique of measuring lipoprotein (a)].
Bussière JL; Josse D; Corbé H; Ricordel I; Ollivier JP
Arch Mal Coeur Vaiss; 1995 Nov; 88(11):1577-82. PubMed ID: 8745991
[TBL] [Abstract][Full Text] [Related]
11. Comparison of lipoprotein(a) assay methods in serum and in a plasminogen-free fraction.
Baldo-Enzi G; Baiocchi M; Crepaldi G
Clin Chim Acta; 1993 Sep; 218(1):83-95. PubMed ID: 8299223
[TBL] [Abstract][Full Text] [Related]
12. Quantification of lipoprotein(a): comparison of an automated latex-enhanced nephelometric assay with an immunoenzymometric method.
Schmidt HH; Genschel JC; Wagner S; Manns MP
Eur J Clin Chem Clin Biochem; 1996 Feb; 34(2):119-24. PubMed ID: 8833643
[TBL] [Abstract][Full Text] [Related]
13. Automated turbidimetry of serum lipoprotein(a).
Borque L; Maside C; Iglesias A
Eur J Clin Chem Clin Biochem; 1993 Dec; 31(12):869-74. PubMed ID: 8136419
[TBL] [Abstract][Full Text] [Related]
14. Immunoturbidimetric determination of lipoprotein(a): improvement in the measurement of turbid and triglyceride-rich samples.
Molinari EA; Pichler PF; Grillhofer H; Kostner GM
Clin Chim Acta; 1995 Feb; 235(1):59-69. PubMed ID: 7634492
[TBL] [Abstract][Full Text] [Related]
15. Effect of lyophilization on determinations of lipoprotein(a) in serum.
Sgoutas DS; Tuten T
Clin Chem; 1992 Jul; 38(7):1355-60. PubMed ID: 1535835
[TBL] [Abstract][Full Text] [Related]
16. Automated latex nephelometric immunoassay for the measurement of serum lipoprotein (a).
Borque L; Rus A; del Cura J; Maside C; Escanero J
J Clin Lab Anal; 1993; 7(2):105-10. PubMed ID: 8505693
[TBL] [Abstract][Full Text] [Related]
17. Is lipoprotein(a)-cholesterol a better predictor of vascular disease events than total lipoprotein(a) mass? A nested case control study from the West of Scotland Coronary Prevention Study.
Gaw A; Brown EA; Docherty G; Ford I
Atherosclerosis; 2000 Jan; 148(1):95-100. PubMed ID: 10580175
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a fully-automated particle-enhanced turbidimetric immunoassay for the measurement of plasma lipoprotein(a). population-based reference values in an area with low incidence of cardiovascular disease.
Simó JM; Camps J; Gómez F; Ferré N; Joven J
Clin Biochem; 2003 Mar; 36(2):129-34. PubMed ID: 12633762
[TBL] [Abstract][Full Text] [Related]
19. Influence of apolipoprotein(a) phenotype on lipoprotein(a) quantification: evaluation of three methods.
Leus FR; Leerink CB; Prins J; van Rijn HJ
Clin Biochem; 1994 Dec; 27(6):449-55. PubMed ID: 7697890
[TBL] [Abstract][Full Text] [Related]
20. Standardization of Lp(a) measurements.
Kostner GM; Steinmetz A
Clin Genet; 1997 Nov; 52(5):393-7. PubMed ID: 9520132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
